"How can I design a prescribing workload ladder (stepwise analgesic treatment

Question

Accepted Answer

Structured prescribing workload ladder Use a condition-agnostic ladder that is anchored to diagnosis, acuity, functional impact, expected recovery time, comorbidity, current medicines, and risks of gastrointestinal harm, cardiovascular events, renal deterioration, overdose, and dependence. ^3 Treat the underlying condition and use non-drug measures alongside analgesia, start with the safest likely effective option, prescribe the lowest effective dose for the shortest necessary period, and build in a clear review and stop plan. ^3 Do not escalate or add another analgesic until the preceding option has been used at a full therapeutic dose and judged insufficient, unless it is contraindicated or not tolerated. ^3 Do not initiate paracetamol, NSAIDs, or opioids for chronic primary pain, defined as pain present for more than 3 months without a clear underlying cause. ^1 ^3 The available PubMed item is an imaging-conference abstract record and supplies no usable procedure-specific analgesic outcome data, so the ladder below is based on the applicable UK prescribing guidance and product indications rather than unsupported procedure-specific claims. (Unknown, 2019) Build every protocol as six repeatable fields Indication and pain phenotype: acute inflammatory or traumatic nociceptive pain, postoperative pain, or persistent structural disease with a defined cause. ^3 Screen: record allergy, pregnancy status where relevant, renal and hepatic function, peptic-ulcer or gastrointestinal-bleeding history, cardiovascular disease, anticoagulants, interacting medicines, alcohol/substance-use risk, current analgesics, and OTC products. ^3 Base analgesic: select paracetamol when appropriate, or an NSAID where short-term musculoskeletal inflammation makes this more useful and risk permits. ^3 Escalation: add or switch only after an adequate trial, reserving opioid treatment for moderate-to-severe pain expected to resolve, pain unresponsive to or unable to use paracetamol and/or NSAIDs, or palliative care. ^3 Quantity and stop date: specify a short course, maximum daily dose, no automatic repeat for acute or postoperative medication, and the review trigger. ^3 Safety-netting: give written and verbal advice, including avoidance of duplicate OTC combination products that could exceed the maximum daily dose of a component. ^3 Stepwise medicines ladder and generic prescription templates Step 0 — non-drug and diagnostic action: document the diagnosis, rehabilitation or physiotherapy plan, activity modification, immobilisation or surgical-team instructions where applicable, and expected pain trajectory before issuing medication. ^3 Step 1 — simple analgesia: “Paracetamol [strength] tablets: take [dose] orally up to [frequency] when required for pain; maximum [daily dose] in 24 hours; for [number] days; review/stop by [date].” Paracetamol is often the preferred initial analgesic, although its use should be individualised. ^3 Step 2 — topical NSAID where suitable: “Topical NSAID [product/strength]: apply [amount] to [site] up to [frequency] daily for [number] days; avoid broken skin; stop if adverse effects; review by [date].” Topical NSAIDs may be used for mild-to-moderate pain and are a reasonable option for chronic musculoskeletal pain when oral NSAIDs are not tolerated. ^2 ^3 Step 3 — short oral NSAID course where suitable: “NSAID [drug/strength]: take [dose] orally [frequency] with or after food for [number] days only; do not take with other NSAIDs; stop when pain settles; review by [date].” An oral NSAID may be more useful for short-term musculoskeletal pain and pain accompanied by inflammation, but requires individual assessment of gastrointestinal, cardiovascular, renal, and other treatment risks. ^3 Step 4 — time-limited rescue opioid only when justified: “Opioid [drug/strength]: take [dose] orally up to [frequency] when required for severe breakthrough pain, maximum [daily dose], for no longer than [number] days; stop as pain improves; no repeat without clinical review.” Opioids are generally reserved for moderate-to-severe pain expected to resolve or when paracetamol and/or NSAIDs are ineffective, contraindicated, or not tolerated. ^3 Step 5 — reassess rather than reflexively repeat: “If pain is worsening, function is deteriorating, medication is ineffective, adverse effects occur, or opioid use persists beyond the planned short course, arrange review and reconsider diagnosis, complication, rehabilitation, and onward management.” Clear review options should be available whenever analgesics are prescribed. ^3 Condition-specific workload pathways Lateral epicondylitis and other tendinopathies: use Step 0 plus a short course of Step 1 or Step 2, progressing to a short oral NSAID course only if there is a convincing inflammatory flare and individual risk assessment supports it. NSAIDs are indicated for acute musculoskeletal disorders including tendinitis, tenosynovitis, bursitis, and periarthritis. ^5 ^6 ^7 Shoulder impingement or periarticular shoulder pain: use Step 0 plus Step 1 or Step 2, with a short oral NSAID course when appropriate; avoid converting persistent symptoms into open-ended analgesic repeats and reassess diagnosis and function. NSAIDs are indicated for acute musculoskeletal disorders including periarthritis and frozen shoulder. ^5 ^6 ^7 Early osteoarthritis: prioritise core non-drug management and shared decision-making, use analgesia episodically for symptom flares, consider topical NSAID before oral NSAID where appropriate, and use paracetamol only infrequently for short-term relief when other options are ineffective, contraindicated, or not tolerated. ^2 Advanced osteoarthritis: use the same risk-based, time-limited approach while addressing functional limitation and definitive management planning; oral NSAIDs can be considered, while routine long-term escalation to opioids is not supported by the mild-to-moderate pain pathway. ^2 ^3 Acute fracture: use Step 1, add Step 3 when inflammation and individual risk profile support NSAID use, and use Step 4 only for severe acute pain with a defined short duration and review. Diclofenac product indications include relief of pain in fractures and painful trauma. ^5 ^6 ^7 Knee arthroscopy, uncomplicated soft-tissue shoulder procedures, carpal tunnel release, ganglion excision, and minor hand procedures: pre-authorise a short Step 1 course, add Step 2 or Step 3 only if appropriate, and reserve a very small Step 4 rescue supply for exceptional severe pain with a documented stop date. Orthopaedic and other minor surgery are recognised NSAID indications. ^5 ^6 ^7 ACL reconstruction, fracture fixation, more extensive shoulder surgery, and hand tendon procedures: use a planned short-course Step 1 base, consider Step 3 where appropriate, and provide Step 4 only as tightly time-limited breakthrough treatment with an early review point and clear handover to the operating team if pain is disproportionate. Orthopaedic surgery and painful trauma are recognised NSAID indications. ^5 ^6 ^7 Total knee replacement and total hip replacement: prescribe only against the discharge analgesia plan, reconcile pre-existing medicines, set a staged de-escalation date, and do not create automatic repeat opioid prescribing; persistent or escalating postoperative pain should trigger clinical reassessment rather than routine continuation. Opioids should be stopped if no longer needed and review arrangements should allow treatment to be altered when ineffective or unnecessary. ^3 Operationalisation in the clinical system Create order sets labelled “acute tendon/soft-tissue flare”, “acute fracture”, “minor orthopaedic/hand operation”, “major orthopaedic operation”, and “osteoarthritis flare”, each containing the same Step 0–5 prompts and editable duration fields. ^3 Require completion of indication, pain score or functional impact, NSAID-risk screen, opioid-risk screen, current OTC analgesics, intended duration, and review date before signing. ^3 Use acute and postoperative prescriptions rather than repeat templates, and make any further supply contingent on review of benefit, harms, adherence, wound or fracture status, and rehabilitation progress. ^3 Include a standard patient instruction: “Use only as directed, do not combine with OTC products containing the same analgesic ingredient, do not take more than the stated maximum daily dose, and seek review if pain worsens or fails to improve as expected.” Written and verbal medicine information and advice about OTC duplication are recommended. ^3

"How can I design a prescribing workload ladder (stepwise analgesic treatment

Key References

Related Knowledge Topics